Adding cytokines to monoclonal antibody therapy: Does the concurrent administration of interleukin-12 add to the efficacy of rituximab in B-cell non-Hodgkin lymphoma?

Stephen M. Ansell

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Adding cytokines to monoclonal antibody therapy: Does the concurrent administration of interleukin-12 add to the efficacy of rituximab in B-cell non-Hodgkin lymphoma?'. Together they form a unique fingerprint.

Medicine & Life Sciences